SCWORK CORP. DL-,01

SCWorx received notice from NASDAQ on April 7 that its stock does not meet the $1.00 minimum bid price requirement and is to be delisted from the Nasdaq Capital Market. A previously granted 180‑day cure period expired on April 6; trading in the common stock is scheduled to be suspended at the market open on April 14. SCWorx has appealed the decision and effected a 1-for-15 reverse stock split on April 7 to boost the share price. To regain compliance, the stock must trade at $1.00 or higher for at least ten consecutive trading days, but success is not guaranteed. » More on de.investing.com

SCWorx has signed a SaaS and data management contract with an integrated health network of more than 700 beds to support the Workday-ERP implementation. Services include data normalization, master data governance, legacy system migration and continuous monitoring of data integrity via SCWorx’s cloud-based platform. The contract strengthens the company’s position in the healthcare sector and aligns with its strategy to generate recurring SaaS revenue from major cloud platforms. » More on de.investing.com

SCWorx has signed a contract with a Midwestern US university hospital (about 500 beds) to provide data-cleansing and enrichment services in support of Workday initiatives. The micro-cap company reportedly has more cash than debt and disclosed no financial details for the new contract. SCWorx also renewed a three-year contract worth about $1.692 million, generated gross proceeds of roughly $721,574 from warrant exercises, announced a partnership for AI-powered payment automation, and received a 180-day Nasdaq extension to regain the minimum bid price until April 6, 2026. » More on de.investing.com

SCWorx has agreed to partner with an unnamed provider of AI-based payment and supply chain automation to integrate its data management modules into the partner’s platform and pursue joint business opportunities in healthcare. The micro-cap highlights this as part of its growth strategy; financial terms were not disclosed. SCWorx also received a 180-day NASDAQ extension until April 6, 2026, reported the renewal of an existing healthcare contract worth about $1.692 million over three years, and disclosed option exercises generating gross proceeds of approximately $721,574. The stock is down roughly 88% year-to-date and trading near its 52-week low. » More on de.investing.com

SCWorx has signed a new three‑year agreement worth approximately $1,692,000 with an existing healthcare partner, an increase of 113% over the previous contract. The customer is expanding the collaboration with additional services and doubling the amount of data processed through the platform. SCWorx also realized gross proceeds of about $721,574 from the exercise of warrants, appointed Anders Ohlsson as CTO, and entered a new partnership with a national healthcare supply chain consulting firm. » More on de.investing.com